To view the press release issued by DEFRA on 4th April 2019 follow the LINK
Q & A’s
What is EVA?
Equine Viral Arteritis (EVA) is a notifiable viral disease that affects horses, mules and donkeys. It is notifiable in all stallions, and in mares that have been mated or inseminated within 14 days. The disease is common in warmblood horses on the continent.
How is EVA spread?
EVA is spread through mating, artificial insemination, contact with aborted foetuses, fomites and also on the breath of infected animals.
Will this affect our application to be a listed country to the EU?
No, EVA is not notifiable in the EU. Most countries require pre-export testing of stallions before they can be imported.
Are there mares in danger? What could happen to the foals?
Mares recover quickly from infection, nevertheless, they are infectious for up to two weeks post infection and can spread the pathogen to their foals through milk; to other susceptible animals through aerosol or nose to nose contact; or to a stallion from further mating in that period. In rare cases the disease can cause severe clinical signs or death in young foals.
Can this disease infect people?
This is a venereal disease of horses and has no impact on humans.
Is there a vaccine available?
A vaccine is available, and routine vaccination against EVA is recommended for stallions and teasers by the HBLB.